Compare EVAX & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVAX | RCON |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | Denmark | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5M | 25.4M |
| IPO Year | 2020 | 2008 |
| Metric | EVAX | RCON |
|---|---|---|
| Price | $2.81 | $1.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.25 | N/A |
| AVG Volume (30 Days) | 41.7K | ★ 147.8K |
| Earning Date | 11-19-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,430,788.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.08 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.72 | $0.02 |
| 52 Week High | $8.10 | $6.42 |
| Indicator | EVAX | RCON |
|---|---|---|
| Relative Strength Index (RSI) | 40.02 | 39.80 |
| Support Level | N/A | $0.79 |
| Resistance Level | $3.62 | $1.44 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 28.57 | 34.09 |
Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.
Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.